Refine by
Pharmaceutical Market Articles & Analysis: Older
21 articles found
Proper execution of pilot scale-up ensures the continuity and success of pharmaceutical products in the market. Services such as those offered by CD Formulation encompass a variety of dosage forms, including tablets, capsules, oral liquids, semi-solids, and complex injections. This phase also involves defining the target product profile, quality attributes, ...
In the ever-evolving pharmaceutical industry, the importance of precision, efficiency, and reliability cannot be overstated, especially when it comes to the manufacturing process. ...
The sleep apnea device market has undergone rapid transformation, driven by growing awareness about the consequences associated with disruptive or poor sleep conditions. Sleep apnea is a severe sleeping disorder in which a person experiences interruptive breathing or loud snoring. Long-term untreated or undiagnosed sleep apnea can cause several health problems, such as daytime sleepiness, ...
Huateng Pharma, a leading supplier of high-quality ingredients for the pharmaceutical and cosmetic industries, is proud to announce its range of novel ingredients designed for both commodities and cosmetics. ...
Drugs originated from marine microorganisms, such as cytarabine (anti-cancer), cephalosporins (anti-microbial), and vidarabine (anti-virus), have been established on the pharmaceutical market. Antibiotics: Novel antibiotics and enzymes are among the early discoveries from metagenomics. ...
Drugs originating from marine microorganisms, such as cytarabine (anti-cancer), cephalosporins (anti-microbial), and vidarabine (anti-virus), have been established on the pharmaceutical market. Antibiotics: Novel antibiotics and enzymes are among the early discoveries from metagenomics. ...
Success doesn’t just come from a winning idea or an exciting new concept. Success comes from having a dedicated team behind that idea, with the enthusiasm and commitment to drive it from concept to clinic. ...
A growing number of governments, pharmaceutical companies and research organisations are choosing Lifebit for its secure, cutting-edge platform and visionary team. ...
ByLifebit
Despite the pandemic and global trade hurdles, Indian pharmaceutical companies continue to be a dominating player in the international pharmaceutical export market. ...
A Technology Platform for Deep-Learning-Based de novo Drug Design Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies. Big data and artificial intelligence (AI) can significantly accelerate many processes and make them more efficient. ...
ByIktos
Iktos Develops a Technology Platform for Deep Learning-Based de novo Drug Development Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies. ...
ByIktos
Drug repurposing not only offers advantages over traditional de novo drug development in terms of cost, speed to market and improved patient outcomes, it can provide unique investment opportunities. ...
We investigate the drivers of value creation in big pharmaceutical firms. We use a unique dataset of a total of 2,200 news items on research and development (R&D) progress announcements and dividend news of 25 largest pharmaceutical companies for the period 1998–2010. ...
In order to contain expenditures for pharmaceuticals, the latest healthcare reforms have focused on decentralising German pharmaceutical market. ...
Those notions are more exposed in the industry which situation directly reflects the quality of human life as in the case of pharmaceutical industry. Better relationships between pharmaceutical companies and physicians and health institutions provide higher level of service to patients. In an empirical study conducted in the pharmaceutical ...
The main objective of this research is to investigate the nature of FDI inflows into the Turkish pharmaceutical industry and examine whether local or multinational firms drive the changing market. ...
This paper tracks the development of genomics between 1990 and 2005 principally within the US context and reviews that development with specific respect to early expectations of genomics-based pharmaceutical innovation, the initial claims made for it, and the realities of its current position. Emphasis is placed on relations between the genomics sector and its larger ...
It argues that policymakers cannot continue to formulate their strategic interventions with an understanding that "strong IPRs are going to help define the pharmaceutical knowledge markets to be competitive and favourable for the development of people oriented innovations". Strategic interventions of the government should make the ...
But the perspectives of therapeutic use of stem cells attract a lot of political and commercial attention to possible new strategic markets opening up new fields besides incumbent bio-pharmaceutical segments. The paper compares experiences of market emergence in recombinant drugs market as a typical ...
Due to its influence on changes of research paradigms and development of hitherto unknown applications, commercialisation of biotechnological knowledge causes new challenges for regulatory procedures in pharmaceutical markets. By affecting time and probability of successful commercialisation, private and public institutions systems of risk management also ...